Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Degarelix acetate prior to or with radiotherapy for prostate cancer Degarelix acetate , Radiotherapy Prostate cancer Male Reproductive Cancer 2023 View  |  Download
LAM-561 in addition to radiation therapy and temozolomide for glioblastoma –adjuvant 2-hydroxyoleic acid (2-OHOA; LP561A1; LAM561) , Radiotherapy , Temozolomide (Temodar; Temodal; SCH 52365) Glioma Neurological Cancer 2021 View  |  Download
Pembrolizumab with radiotherapy and chemotherapy for treating unresectable oesophageal cancer Chemotherapy , Pembrolizumab (Keytruda; MK-3475) , Radiotherapy Oesophageal cancer Head and Neck Cancer 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications